$PLUR
Pluri Inc. Stock $plur

$plur Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023086065 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$105.0K	$54.00K
YoY Change	5150.0%	-37.93%
Cost Of Revenue
YoY Change
Gross Profit		$54.00K
YoY Change
Gross Profit Margin		100.0%
Selling, General & Admin	$2.354M	$2.440M
YoY Change	-18.72%	-10.95%
% of Gross Profit		4518.52%
Research & Development	$2.964M	$3.366M
YoY Change	-35.21%	-25.25%
% of Gross Profit		6233.33%
Depreciation & Amortization	$61.00K	$67.00K
YoY Change	-37.11%	-33.0%
% of Gross Profit		124.07%
Operating Expenses	$2.964M	$3.366M
YoY Change	-35.21%	-25.25%
Operating Profit	-$5.213M	-$5.377M
YoY Change	-21.95%	-22.33%
Interest Expense	$216.0K	$214.0K
YoY Change	-201.89%	-210.31%
% of Operating Profit
Other Income/Expense, Net	$219.0K	$279.0K
YoY Change	-116.07%	-67.1%
Pretax Income	-$4.994M	-$5.100M
YoY Change	-39.5%	-18.65%
Income Tax
% Of Pretax Income
Net Earnings	-$4.905M	-$4.961M
YoY Change	-39.57%	-18.95%
Net Earnings / Revenue	-4671.43%	-9187.04%
Basic Earnings Per Share	-$0.12	-$0.12
Diluted Earnings Per Share	-$0.12	-$0.12
COMMON SHARES
Basic Shares Outstanding	41.48M shares	41.35M shares
Diluted Shares Outstanding	41.53M shares	41.33M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.62M	$33.61M
YoY Change	-35.19%	-30.0%
Cash & Equivalents	$5.468M	$5.253M
Short-Term Investments	$25.15M	$28.36M
Other Short-Term Assets	$1.632M	$1.650M
YoY Change	-43.61%	-3.4%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$32.25M	$35.26M
YoY Change	-35.68%	-29.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$788.0K	$768.0K
YoY Change	17.09%	8.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$79.00K	$7.000K
YoY Change	-18.56%	40.0%
Total Long-Term Assets	$9.312M	$9.284M
YoY Change	-4.85%	-7.45%
TOTAL ASSETS
Total Short-Term Assets	$32.25M	$35.26M
Total Long-Term Assets	$9.312M	$9.284M
Total Assets	$41.56M	$44.54M
YoY Change	-30.64%	-25.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.104M	$970.0K
YoY Change	-12.17%	-27.01%
Accrued Expenses	$1.012M	$1.024M
YoY Change	-32.85%	2.91%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.530M	$4.322M
YoY Change	-14.27%	-13.87%
LONG-TERM LIABILITIES
Long-Term Debt	$24.40M	$23.17M
YoY Change	7.61%	11.81%
Other Long-Term Liabilities	$6.016M	$6.010M
YoY Change	-14.08%	-15.51%
Total Long-Term Liabilities	$30.42M	$29.18M
YoY Change	2.49%	4.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.530M	$4.322M
Total Long-Term Liabilities	$30.42M	$29.18M
Total Liabilities	$34.95M	$33.50M
YoY Change	-0.04%	1.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$409.5M	-$404.5M
YoY Change	6.21%	7.2%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.399M	$8.901M
YoY Change
Total Liabilities & Shareholders Equity	$41.56M	$44.54M
YoY Change	-30.64%	-25.46%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$4.905M	-$4.961M
YoY Change	-39.57%	-18.95%
Depreciation, Depletion And Amortization	$61.00K	$67.00K
YoY Change	-37.11%	-33.0%
Cash From Operating Activities	-$3.646M	-$5.857M
YoY Change	-41.94%	-23.03%
INVESTING ACTIVITIES
Capital Expenditures	$124.0K	$103.0K
YoY Change	82.35%	41.1%
Acquisitions
YoY Change
Other Investing Activities	$4.035M	$5.910M
YoY Change	447.49%	-8.6%
Cash From Investing Activities	$3.921M	$5.802M
YoY Change	486.1%	-9.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	-3.646M	-$5.857M
Cash From Investing Activities	3.921M	$5.802M
Cash From Financing Activities	0.000
Net Change In Cash	275.0K	-$97.00K
YoY Change	235.37%	-92.98%
FREE CASH FLOW
Cash From Operating Activities	-$3.646M	-$5.857M
Capital Expenditures	$124.0K	$103.0K
Free Cash Flow	-$3.770M	-$5.960M
YoY Change	-40.61%	-22.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q3	dei	Entity File Number EntityFileNumber	001-31392
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	PLURI INC.
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0351734
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	MATAM Advanced Technology Park
CY2023Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Building No. 5
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Haifa
CY2023Q3	dei	Entity Address Country EntityAddressCountry	IL
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	3508409
CY2023Q3	dei	Security12b Title Security12bTitle	Common Shares, par value $0.00001
CY2023Q3	dei	Trading Symbol TradingSymbol	PLUR
CY2023Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41480172	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5253000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5360000	usd
CY2023Q3	plur	Shortterm Bank Deposits ShorttermBankDeposits	28356000	usd
CY2023Q2	plur	Shortterm Bank Deposits ShorttermBankDeposits	34811000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	295000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	269000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1354000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	969000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	35258000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	41409000	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	611000	usd
CY2023Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	627000	usd
CY2023Q3	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	426000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	439000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	768000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	688000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7472000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7633000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1000	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	9284000	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	9388000	usd
CY2023Q3	us-gaap	Assets Assets	44542000	usd
CY2023Q2	us-gaap	Assets Assets	50797000	usd
CY2023Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	973000	usd
CY2023Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1812000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1024000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1209000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	643000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	627000	usd
CY2023Q3	plur	Accrued Vacations Current AccruedVacationsCurrent	689000	usd
CY2023Q2	plur	Accrued Vacations Current AccruedVacationsCurrent	873000	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	993000	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1100000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4322000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5621000	usd
CY2023Q3	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	580000	usd
CY2023Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	598000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5430000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5748000	usd
CY2023Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	23172000	usd
CY2023Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	23530000	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29182000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29876000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41448521	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41448521	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41245495	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41245495	shares
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	413446000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	412939000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-404545000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399584000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	8901000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13355000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	2137000	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	1945000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11038000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15300000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44542000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50797000	usd
CY2023Q3	us-gaap	Revenues Revenues	54000	usd
CY2022Q3	us-gaap	Revenues Revenues	87000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3366000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4503000	usd
CY2023Q3	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	373000	usd
CY2022Q3	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	233000	usd
CY2023Q3	plur	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	2993000	usd
CY2022Q3	plur	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	4270000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2438000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2740000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5377000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6923000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	214000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	194000	usd
CY2023Q3	plur	Financial Income FinancialIncome	493000	usd
CY2022Q3	plur	Financial Income FinancialIncome	848000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	279000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	654000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-5098000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-6269000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-137000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-148000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4961000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6121000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41331764	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32562596	shares
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32186000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	984000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-6269000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26901000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15300000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	836000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-5098000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11038000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-5098000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-6269000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	67000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	100000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	836000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	984000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	391000	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-674000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-883000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-450000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-476000	usd
CY2022Q3	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1344000	usd
CY2023Q3	plur	Decrease In Operating Lease Right Of Use Asset And Liability DecreaseInOperatingLeaseRight-Of-UseAssetAndLiability	141000	usd
CY2022Q3	plur	Decrease In Operating Lease Right Of Use Asset And Liability DecreaseInOperatingLeaseRight-Of-UseAssetAndLiability	15000	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	180000	usd
CY2022Q3	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	493000	usd
CY2023Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	772000	usd
CY2022Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	166000	usd
CY2023Q3	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-358000	usd
CY2022Q3	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-957000	usd
CY2023Q3	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-5000	usd
CY2022Q3	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-5000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5857000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7609000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	103000	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	73000	usd
CY2023Q3	plur	Proceeds From Withdrawal Of Shortterm Deposits ProceedsFromWithdrawalOfShorttermDeposits	5905000	usd
CY2022Q3	plur	Proceeds From Withdrawal Of Shortterm Deposits ProceedsFromWithdrawalOfShorttermDeposits	6466000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5802000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6393000	usd
CY2023Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-42000	usd
CY2022Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-166000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-97000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1382000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6256000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11413000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6159000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10031000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	5253000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	8744000	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	295000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	653000	usd
CY2023Q3	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	611000	usd
CY2022Q3	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	634000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6159000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10031000	usd
CY2023Q3	plur	Purchase Of Property And Equipment On Credit PurchaseOfPropertyAndEquipmentOnCredit	118000	usd
CY2022Q3	plur	Purchase Of Property And Equipment On Credit PurchaseOfPropertyAndEquipmentOnCredit	20000	usd
CY2023Q3	plur	Supplemental Noncash Information Related To Lease Liabilities Arising From Obtaining Rightofuse As SupplementalNoncashInformationRelatedToLeaseLiabilitiesArisingFromObtainingRightofuseAs	25000	usd
CY2023Q3	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>c.</i></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of estimates</i></b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p>
CY2020Q2	plur	Subsidiary Loan SubsidiaryLoan	50000000	eur
CY2021Q2	plur	First Tranche Price FirstTranchePrice	20000000	eur
CY2021Q2	plur	Annual Interest Percentage AnnualInterestPercentage	0.04	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1003873	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	27951	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	183025	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	106546	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	470694	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1800517	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	456779	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1770417	shares
CY2023Q3	plur	Cash And Deposits CashAndDeposits	906000	usd
CY2023Q3	plur	Percentage Of Qualified Expenditures PercentageOfQualifiedExpenditures	0.50	pure
CY2023Q3	plur	Royalty Rate Sales RoyaltyRateSales	0.03	pure
CY2023Q3	plur	Royalty Rate Payable On Grants Received RoyaltyRatePayableOnGrantsReceived	1	pure
CY2023Q3	plur	Contingent Liability In Respect To Royalties ContingentLiabilityInRespectToRoyalties	27564000	usd
CY2020Q2	plur	Subsidiary Loan SubsidiaryLoan	50000000	eur
CY2023Q3	plur	Contractual Interest Rate For Funds Borrowed ContractualInterestRateForFundsBorrowed	0.04	pure
CY2023Q3	plur	Deferred Interest Rate Percentage DeferredInterestRatePercentage	0.04	pure
CY2021Q2	plur	First Tranche Price FirstTranchePrice	20000000	eur
CY2021Q2	plur	Annual Interest Percentage AnnualInterestPercentage	0.04	pure
CY2023Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	21198000	usd
CY2023Q3	plur	Accrued Interest AccruedInterest	1974000	usd
CY2022Q3	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	11800000000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1657592	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1935014	shares
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38000	usd
CY2023Q3	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1000	usd
CY2023Q3	plur	Aggregate Amount AggregateAmount	2500000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate	0.80	pure
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32562596	shares
CY2022Q3	plur	Modification Of Warrants To Noncontrolling Interests ModificationOfWarrantsToNoncontrollingInterests		usd
CY2022Q3	plur	Supplemental Noncash Information Related To Lease Liabilities Arising From Obtaining Rightofuse As SupplementalNoncashInformationRelatedToLeaseLiabilitiesArisingFromObtainingRightofuseAs		usd
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001158780

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001213900-23-086065-index-headers.html	Edgar Link	pending
0001213900-23-086065-index.html	Edgar Link	pending
0001213900-23-086065.txt	Edgar Link	pending
0001213900-23-086065-xbrl.zip	Edgar Link	pending
f10q0923ex31-1_pluriinc.htm	Edgar Link	pending
f10q0923ex31-2_pluriinc.htm	Edgar Link	pending
f10q0923ex32-1_pluriinc.htm	Edgar Link	pending
f10q0923ex32-2_pluriinc.htm	Edgar Link	pending
f10q0923_pluriinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
plur-20230930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
plur-20230930_cal.xml	Edgar Link	unprocessable
plur-20230930_def.xml	Edgar Link	unprocessable
plur-20230930_lab.xml	Edgar Link	unprocessable
plur-20230930_pre.xml	Edgar Link	unprocessable
f10q0923_pluriinc_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLUR
Pluri Inc. Stock $plur

2023 Q4 Form 10-Q Financial Statement

#000121390023086065 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR Pluri Inc. Stock $plur

2023 Q4 Form 10-Q Financial Statement

#000121390023086065 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR
Pluri Inc. Stock $plur